Vijay Garud Bhoj, MD, PhD
Pathology and Laboratory Medicine
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Penn Medicine Provider

About me

  • Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: University of Texas Southwestern Medical Center
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Bhoj is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Guruprasad P, Ramasubramanian R, Nason S, Carturan A, Liu S, Paruzzo L, Hornet V, Plesset J, Patel RP, Bhoj V, Beatty GL, Ruella M. Manufacturing of CRISPR-edited primary mouse CAR T cells for cancer immunotherapy , Nature Protocols: 2025


Doshi BS, Markmann CA, Novak N, Rojas SJ, Davidson R, Chau JQ, Wang W, Carrig S, Rus CM, Samelson-Jones BJ, Small JC, Bhoj VG*, George LA* Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies , Molecular Therapy: 2025


Papadaki GF, Li Y, Monos DS, Bhoj VG Cars pick up another passenger: Organ transplantation , Human Immunology: 2024


Lee K, Chau JQ, Suber YB, Sternberg AR, Pishko AM, George LA, Bhoj VG, Doshi BS, Samelson-Jones BJ Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab , Blood: 2024


Mack EA, Dougher MC, Ginda A, Cahill CQ, Murter M, Schell K, Tanhehco YC, Bhoj V, Fesnak AD, Siegel DL, Kambayashi T, Aqui N, O'Doherty U Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis , Blood: 2024


Agarwal D, Liu C, Bhoj V, Kearns J, Bharani T, Choe I, Vivek K, O'Connor DH, Wiseman RW, Duquesnoy RJ, Naji A, Kamoun M Adaptation of HLA testing to characterize the cynomolgus macaque MHC polymorphisms and alloantibody signatures. , HLA: 2024


Zhang Z, Markmann C, Yu M, Agarwal D, Rostami S, Wang W, Liu C, Zhao H, Ochoa T, Parvathaneni K, Xu X, Li E, Gonzalez V, Khadka R, Hoffmann J, Knox JJ, Scholler J, Marcellus B, Allman D, Fraietta JA, Samelson-Jones B, Milone MC, Monos D, Garfall AL, Naji A*, Bhoj VG* Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies , Cell Report Medicine: 2023


Baglaenko Y, Wagner C, Bhoj VG, Brodin P, Gershwin ME, Graham D, Invernizzi P, Kidd KK, Korsunsky I, Levy M, Mammen AL, Nizet V, Ramirez-Valle F, Stites EC, Williams MS, Wilson M, Rose NR, Ladd V, Sirota M Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disorders. , Cambridge Prisms: Precision Medicine: 2023


Mireia Uribe-Herranz, Silvia Beghi, Marco Ruella, Kalpana Parvathaneni, Silvano Salaris, Nektarios Kostopoulos, Subin S. George, Stefano Pierini, Guido Ghirardi, Kimberly V. Amelsberg, Yong Gu Lee, Raymone Pajarillo, Caroline Markmann, Bevin McGettigan-Croce, Noelle Frey, Simon F. Lacey, John Scholler, Khatuna Gabunia, Gary Wu, Elise Chong, David L. Porter, Carl H. June, Stephen J. Schuster, Vijay Bhoj and Andrea Facciabene Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy , Molecular Therapy: 2023


Kavitha Muralidharan, Divyansh Agarwal, Ali Naji, and Vijay G. Bhoj Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity , The Journal of Immunology, 209(10): 2022,1811-1816


View all publications